Literature DB >> 193681

Inhibition of thyrotropin- and dibutyryl cyclic AMP-induced secretion of thyroxine and triiodothyronine by catecholamines.

M L Maayan, A F Debons, I Krimsky, E M Volpert, A From, F Dawry, E Siclari.   

Abstract

Thyrotropin (TSH), 1 MU/ml and N6, O2'-dibutyryl adenosine 3',5-cyclic monophosphoric acid (dbcAMP) greatly enhanced the release of thyroxine (T4) and triiodothyronine (T3) from mouse thyroids incubated in vitro. L-Epinephrine (E) and L-norepinephrine (NE) strongly inhibited the TSH and dbcAMP-stimulated release of thyroid hormones; L-isoproterenol (IPNE) exerted a relatively weak inhibition. The inhibition by catecholamines was prevented by the alpha-adrenergic blocker, phentolamine; L-propranolol, a beta-adrenergic blocker, had no effect on the inhibition. The TSH-induced release of thyroid hormones was not affected by adrenergic blockers. Epinephrine did not affect the increase in thyroidal cAMP content induced by TSH. These results indicate that catecholamines act by way of an alpha-adrenergic receptor to suppress TSH-stimulated release of thyroid hormones at a point beyond cAMP formation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 193681     DOI: 10.1210/endo-101-1-284

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  3 in total

1.  Alpha 1-adrenergic regulation of thyrotropin-stimulated release of 3, 5, 3' -triiodothyronine and thyroxine from perifused mouse thyroid.

Authors:  Y Oda; K Tajima; M Mori-Tanaka; I Matsui; K Kitajima; J Miyagawa; T Hanafusa; K Mashita; S Tarui
Journal:  J Endocrinol Invest       Date:  1991-11       Impact factor: 4.256

2.  Norepinephrine and TSH: effects on thyroidal radioiodine and thyroxine release.

Authors:  M L Maayan; E M Volpert
Journal:  J Endocrinol Invest       Date:  1989-12       Impact factor: 4.256

3.  An in vitro procedure for the estimation of thyroid hormone releasing factors in sera of thyrotoxic patients.

Authors:  M L Maayan; E M Volpert; F P Dawry
Journal:  J Endocrinol Invest       Date:  1978-10       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.